NCT04637503 2020-11-19
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
Shenzhen Geno-Immune Medical Institute
St. Anna Kinderkrebsforschung
National University Hospital, Singapore
Tehran University of Medical Sciences